Education
About Us
Working with TipRanks
Follow Us
Imugene Ltd (IUGNF)
:IUGNF
Total Valuation
Imugene has a market cap or net worth of $48.85M. The enterprise value is $85.79M.
Market Cap$48.85M
Enterprise Value$85.79M
Share Statistics
Imugene has 288,497,340 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding288,497,340
Owned by Insiders5.40%
Owned by Institutions<0.01%
Financial Efficiency
Imugene’s return on equity (ROE) is -1.27 and return on invested capital (ROIC) is -111.14%.
Return on Equity (ROE)-1.27
Return on Assets (ROA)-0.99
Return on Invested Capital (ROIC)-111.14%
Return on Capital Employed (ROCE)-1.15
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.07
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Imugene is ―. Imugene’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value3.30
Price to FCF―
Price to Operating Cash Flow-0.71
PEG Ratio―
Income Statement
In the last 12 months, Imugene had revenue of 10.81M and earned -149.68M in profits. Earnings per share was -0.72.
Revenue10.81M
Gross Profit4.97M
Operating Income-140.93M
Pretax Income-154.30M
Net Income-149.68M
EBITDA-147.98M
Earnings Per Share (EPS)-0.72
Cash Flow
In the last 12 months, operating cash flow was -87.52M and capital expenditures -8.72M, giving a free cash flow of -96.24M billion.
Operating Cash Flow-87.52M
Free Cash Flow-96.24M
Free Cash Flow per Share-0.33
Dividends & Yields
Imugene pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.82
52-Week Price Change-84.21%
50-Day Moving Average0.25
200-Day Moving Average0.67
Relative Strength Index (RSI)51.23
Average Volume (3m)23.90K
Important Dates
Imugene upcoming earnings date is Mar 4, 2026, TBA (Confirmed).
Last Earnings DateAug 27, 2025
Next Earnings DateMar 4, 2026
Ex-Dividend Date―
Financial Position
Imugene as a current ratio of 3.86, with Debt / Equity ratio of 24.90%
Current Ratio3.86
Quick Ratio3.86
Debt to Market Cap<0.01
Net Debt to EBITDA0.62
Interest Coverage Ratio-294.61
Taxes
In the past 12 months, Imugene has paid -4.62M in taxes.
Income Tax-4.62M
Effective Tax Rate0.03
Enterprise Valuation
Imugene EV to EBITDA ratio is -2.02, with an EV/FCF ratio of -2.79.
EV to Sales27.60
EV to EBITDA-2.02
EV to Free Cash Flow-2.79
EV to Operating Cash Flow-2.93
Balance Sheet
Imugene has $33.74M in cash and marketable securities with $15.76M in debt, giving a net cash position of -$17.99M billion.
Cash & Marketable Securities$33.74M
Total Debt$15.76M
Net Cash-$17.99M
Net Cash Per Share-$0.06
Tangible Book Value Per Share$0.40
Margins
Gross margin is 100.00%, with operating margin of -1303.71%, and net profit margin of -1384.65%.
Gross Margin100.00%
Operating Margin-1303.71%
Pretax Margin-1427.35%
Net Profit Margin-1384.65%
EBITDA Margin-1368.90%
EBIT Margin-1422.92%
Analyst Forecast
The average price target for Imugene is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price Target―
Price Target Upside―
Analyst ConsensusModerate Sell
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―